Results
When islets perifused with a 0.1% glucose solution were exposed to 0.3% of glucose, IRI amounts in the out-flow of the perifusate rose biphasically. As shown in Fig. 2 , the 1st phase response occurred immediately after the application of high levels of glucose, and the duration of the response was 3 min or less. The 2nd phase response was a delayed response that was 
Discussion
The establishment of the Lacy's perifusion technique and its use on isolated rat pancreas islets has enabled us to observe the function-mode of the pancreas islets analytically. Some observations of insulin-release after glucose application have been reported. For instance, when rat islet preparation perifused with Hanks' solution including 0.1% of glucose was exposed to 0.3% of glucose solution, IRI in the out-flow of the perifusate rose biphasically. As reported previously the 1st phase response was thought to be due to insulin-release from the B-cells and the 2nd phase response due to the increase of insulin-synthesis in the B-cells. The mechanism for the response, however, still remains unclear. The modified method used in the present experiment is a simplified and stabilized micro-method and is ideal for the analytical investigation of the functions of pancreas islet cells because the number of islets observed can be reduced and observation can be easily repeated.
The 1st phase response, which was caused by shortening the high level glucose application time, had a certain threshold ranging from 0.14 to 0.2% of glucose, and was seen to be an all or nothing response (as shown in Fig. 4) . The peak of the 1st phase response is considered to be related to the insulin content of the B-cells, which depends on the glucose concentration in the preincubation medium. As reported by Zawalich, the increase of glucose concentration in the perifusion medium has a strong effect on insulin-release from the B-cells. The present data do not contradict Zawalich's report, since the concentration of glucose in the preincubation medium was kept at 0.1% in our experiments.
Curry and Bennett have reported that the 1st phase of secretion is approximately 25 to 50
times more sensitive to somatostatin inhibition than is the 2nd phase and that calcium added to the perfusate inhibits somatostatin action in the 2nd phase, but has no effect in the 1st phase .
Their complicated results can not be explained by the model in which both the glucosechemoreceptor and somatostatin receptor are distributed in a parallel manner on the same cell membrane. Since it is well known that somatostatin is released from D-cells to B-cells, it is natural to assume that somatostatin receptors are distributed on the B-cell membrane. On the other hand, the glucose-chemoreceptor can not be presumed to be on the B-cell membrane. Since the response through glucose-chemoreceptor is also found in the short applicating glucose experiment, the contribution of synthesis of insulin in B-cells was disproved. All these results indicate that the 1st phase response was induced by impulses from the glucose-chemoreceptors , which are presumed to be distributed on the cell membranes of cells other than B-cells. The 2nd phase delayed response was reported to be induced by an increase of insulin-synthesis in the B-cells because an increase in glucose-uptake induced by high concentrations of glucose in the perifusion medium activated the energy supplying system in the B-cells. Consequently, the configuration of IRI-increasing curves is thought to be determined by the overlapping of two different response curves, one depending on B-cell function and the other on the D-cells .
Since somatostatin secreted from D-cells is known to inhibit the insulin-release from Bcells, the 1st phase response could be provoked by an abrupt stop of somatostatin release from D-cells. In other words, the decrease of somatostatin control induced by a signal from the glucosechemoreceptor may result in an increase of insulin turnover rate (in-out) across the B-cell membranes.
The above stated supposition is partially seen in the present results in that a certain amount of synthetic somatostatin depressed the insulin release from the B-cells when the islets were 
